Fenghai Duan

4.1k total citations · 1 hit paper
96 papers, 2.8k citations indexed

About

Fenghai Duan is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Fenghai Duan has authored 96 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 42 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Oncology. Recurrent topics in Fenghai Duan's work include Lung Cancer Diagnosis and Treatment (28 papers), Medical Imaging Techniques and Applications (24 papers) and Radiomics and Machine Learning in Medical Imaging (24 papers). Fenghai Duan is often cited by papers focused on Lung Cancer Diagnosis and Treatment (28 papers), Medical Imaging Techniques and Applications (24 papers) and Radiomics and Machine Learning in Medical Imaging (24 papers). Fenghai Duan collaborates with scholars based in United States, New Zealand and China. Fenghai Duan's co-authors include Barry A. Siegel, Bradley S. Snyder, Caroline Chiles, Ilana F. Gareen, Constantine Gatsonis, Anthony F. Shields, Bruce E. Hillner, Lucy Hanna, David S. Gierada and Denise R. Aberle and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fenghai Duan

87 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Results of the Two Incidence Screenings in the National Lung Screening Trial

2013 400 citations Fenghai Duan, Ilana F. Gareen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fenghai Duan United States	32	1.5k	1.3k	578	339	259	96	2.8k
Chris R. Kelsey United States	35	2.5k 1.6×	1.2k 1.0×	981 1.7×	395 1.2×	226 0.9×	160	3.9k
Javier F. Torres–Roca United States	29	963 0.6×	722 0.6×	938 1.6×	613 1.8×	696 2.7×	82	2.7k
Ramesh Rengan United States	33	2.2k 1.4×	1.3k 1.0×	914 1.6×	274 0.8×	173 0.7×	157	3.5k
Naohiro Kajiwara Japan	27	1.6k 1.0×	452 0.4×	461 0.8×	289 0.9×	153 0.6×	91	2.5k
John M. Corman United States	24	1.2k 0.8×	256 0.2×	807 1.4×	469 1.4×	167 0.6×	90	2.4k
Terence T. Sio United States	23	914 0.6×	394 0.3×	343 0.6×	168 0.5×	81 0.3×	126	1.8k
John C. Kucharczuk United States	32	2.1k 1.4×	546 0.4×	565 1.0×	473 1.4×	255 1.0×	108	3.8k
Stephan Korom Switzerland	21	1.2k 0.7×	751 0.6×	735 1.3×	404 1.2×	154 0.6×	60	3.1k
Ananya Choudhury United Kingdom	34	1.3k 0.8×	1.0k 0.8×	997 1.7×	885 2.6×	543 2.1×	214	4.1k
Abraham Chachoua United States	24	1.6k 1.0×	414 0.3×	2.7k 4.7×	764 2.3×	280 1.1×	75	3.9k

Countries citing papers authored by Fenghai Duan

Since Specialization

Citations

This map shows the geographic impact of Fenghai Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghai Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghai Duan more than expected).

Fields of papers citing papers by Fenghai Duan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenghai Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghai Duan. The network helps show where Fenghai Duan may publish in the future.

Co-authorship network of co-authors of Fenghai Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Fenghai Duan. A scholar is included among the top collaborators of Fenghai Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenghai Duan. Fenghai Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duan, Fenghai, et al.. (2025). Listeria monocytogenes Modulates Macrophage Inflammatory Responses to Facilitate Its Intracellular Survival by Manipulating Macrophage-Derived Exosomal ncRNAs. Microorganisms. 13(2). 410–410.

Bandos, Hanna, Pedro A. Torres‐Saavedra, Eva Culakova, et al.. (2025). Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials. JNCI Monographs. 2025(68). 14–21. 3 indexed citations

Hollenbeak, Christopher S., Fenghai Duan, Rathan M. Subramaniam, et al.. (2024). Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685. Head & Neck. 46(8). 1988–1998.

Kyriakopoulos, Christos E., Yu‐Hui Chen, Robert Jeraj, et al.. (2024). Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153).. Journal of Clinical Oncology. 42(17_suppl). LBA5000–LBA5000. 2 indexed citations

Duan, Fenghai, J.K. Chang, Zitao Liu, et al.. (2024). Deciphering endocrine function of adipose tissue and its significant influences in obesity-related diseases caused by its dysfunction. Differentiation. 141. 100832–100832. 4 indexed citations

Hopkins, Raewyn J., Fenghai Duan, Greg Gamble, et al.. (2021). Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers. Thorax. 76(3). 272–280. 11 indexed citations

Han, Dae Hee, et al.. (2021). Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial. Journal of Thoracic Oncology. 16(7). 1118–1126. 3 indexed citations

Maldonado, Fabien, Srinivasan Rajagopalan, Fenghai Duan, et al.. (2020). Validation of the BRODERS classifier (BenignversusaggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules. European Respiratory Journal. 57(4). 2002485–2002485. 22 indexed citations

Billatos, Ehab, Fenghai Duan, Elizabeth Moses, et al.. (2019). Detection of early lung cancer among military personnel (DECAMP) consortium: study protocols. BMC Pulmonary Medicine. 19(1). 59–59. 15 indexed citations

10.

Hopkins, Raewyn J., Robert P. Young, Fenghai Duan, et al.. (2017). Chromosome 15q25 locus and genetic susceptibility to lung cancer, COPD, and smoking: Triple whammy effect in the ACRIN-NLST cohort sub-study (N=10,054). Respiratory Medicine. 132. 279–279. 1 indexed citations

11.

Gierada, David S., Paul F. Pinsky, Fenghai Duan, et al.. (2017). Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. European Radiology. 27(8). 3249–3256. 19 indexed citations

12.

Ohri, Nitin, Fenghai Duan, Bradley S. Snyder, et al.. (2016). Pretreatment¹⁸F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235. Journal of Nuclear Medicine. 57(6). 842–848. 73 indexed citations

13.

Young, Robert P., Fenghai Duan, Caroline Chiles, et al.. (2015). Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. American Journal of Respiratory and Critical Care Medicine. 192(9). 1060–1067. 96 indexed citations

14.

Maldonado, Fabien, Fenghai Duan, Sushravya Raghunath, et al.. (2015). Noninvasive Computed Tomography–based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. American Journal of Respiratory and Critical Care Medicine. 192(6). 737–744. 43 indexed citations

15.

Hillner, Bruce E., Barry A. Siegel, Lucy Hanna, et al.. (2015). ¹⁸F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry. Journal of Nuclear Medicine. 56(2). 222–228. 66 indexed citations

16.

Yu, Evan Y., Fenghai Duan, Mark Muzi, et al.. (2015). Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by ¹⁸F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Survival: Results from American College of Radiology Imaging Network 6687. Journal of Nuclear Medicine. 56(3). 354–360. 51 indexed citations

17.

Yu, Evan Y., Fenghai Duan, Mark Muzi, et al.. (2013). Effects of dasatinib on prostate cancer bone metastases and normal bone measured by 18F-fluoride PET: Preliminary results from ACRIN 6687. 54(4). 289–289. 2 indexed citations

18.

Hillner, Bruce E., Barry A. Siegel, Lucy Hanna, et al.. (2012). Impact of ¹⁸F-FDG PET Used After Initial Treatment of Cancer: Comparison of the National Oncologic PET Registry 2006 and 2009 Cohorts. Journal of Nuclear Medicine. 53(5). 831–837. 25 indexed citations

19.

Duan, Fenghai, Lynette M. Smith, Roddy S. O’Connor, et al.. (2011). Genomic and Clinical Analysis of Amplification of the 13q31 Chromosomal Region in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 17(6). 1463–1473. 50 indexed citations

20.

Duan, Fenghai, et al.. (2007). Intercenter reliability and validity of the rhesus macaque GeneChip. BMC Genomics. 8(1). 61–61. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact